The desperate need for good-quality clinical trials to evaluate the optimal source and dose of fibrinogen in managing bleeding

Critical Care

Volumn 15, Issue 6, 2011, Pages

  Stanworth, Simon J ^a   Hunt, Beverley J ^b,c  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; FRESH FROZEN PLASMA; HEMOSTATIC AGENT;

BLEEDING; BLOOD TRANSFUSION; CLINICAL STUDY; COLLOID; COST EFFECTIVENESS ANALYSIS; CRYOPRECIPITATE; CRYSTALLOID; HEMOSTASIS; INTENSIVE CARE; NOTE; OUTCOME ASSESSMENT; PATIENT SAFETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK BENEFIT ANALYSIS; VENOUS THROMBOEMBOLISM; HUMAN; INJURY; METHODOLOGY; PLASMA;

BLOOD TRANSFUSION; FIBRINOGEN; HEMOSTATICS; HUMANS; PLASMA; WOUNDS AND INJURIES;

EID: 81255195899     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc10510     Document Type: Note

References (8)

1. Kozek-Langenecker S, Sorenson B, Hess J, Spahn DR. Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: a systematic review. Crit Care 2011, 15(5):R239. 10.1186/cc10488, 21999308.
2. Moher D, Liberati A, Tetzlaff J, Altman DG, . The PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement. PLoS Med 2009, 6:e1000097. 10.1371/journal.pmed.1000097, 2707599, 19621072, The PRISMA Group.
3. Schulz KF, Altman DG, Moher D, . CONSORT Group CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. PLoS Med 2010, 7:e1000251. 10.1371/journal.pmed.1000251, 2844794, 20352064, CONSORT Group.
4. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, . STROBE Initiative The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007, 370:1453-1457. 10.1016/S0140-6736(07)61602-X, 18064739, STROBE Initiative.
5. Chalmers I. The scandalous failure of scientists to cumulate scientifically. Abstract to paper presented at: Ninth World Congress on Health Information and Libraries; 20-23 Sept. 2005 Salvador, Brazil., http://www.icml9.org/program/activity.php?lang=en&id=36
6. Fergusson DA, Hébert PC, Mazer CD, Fremes S, MacAdams C, Murkin JM, Teoh K, Duke PC, Arellano R, Blajchman MA, Bussières JS, Côté D, Karski J, Martineau R, Robblee JA, Rodger M, Wells G, Clinch J, Pretorius R, . BART Investigators A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 2008, 358:2319-2331. 10.1056/NEJMoa0802395, 18480196, BART Investigators.
7. Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, Herrera J, Hunt B, Iribhogbe P, Izurieta M, Khamis H, Komolafe E, Marrero MA, Mejía-Mantilla J, Miranda J, Morales C, Olaomi O, Olldashi F, Perel P, Peto R, Ramana PV, Ravi RR, Yutthakasemsunt S. CRASH-2 trial collaborators Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010, 376:23-32. CRASH-2 trial collaborators.
8. Curry N, Hopewell S, Dorée C, Hyde C, Brohi K, Stanworth S. The acute management of trauma hemorrhage: a systematic review of randomized controlled trials. Crit Care 2011, 15:R92. 10.1186/cc10096, 21392371.